Ectopic Pregnancy – Comprehensive Study Notes

Definition & Core Concept

  • Ectopic Pregnancy (EP)

    • Implantation of the fertilized ovum outside the endometrial lining of the uterine cavity.

    • In simplest terms, it is a "misplaced implantation,” where the embryo starts growing in tissue that cannot sustain a normal pregnancy.

    • Mechanistic root: obstruction to, or slowing of, the normal passage of the zygote through the fallopian tube into the uterine cavity.

  • Epidemiologic Pearls

    • ≥90%90\% of ectopic gestations occur in a segment of the uterine tube, hence the synonym "tubal pregnancy."

    • Of tubal cases, about 70%70\% localize in the ampullary (widest) segment.

    • Less‐common sites (descending frequency): isthmus, interstitial (cornual), fimbrial end, tubo-ovarian ligament, ovary, peritoneal (abdominal) cavity, and cervix.

Pathophysiology & Etiology

  • Normal transport review

    • Fertilized ovum relies on ciliary action + smooth-muscle peristalsis to reach the uterus (≈ 3–43\text{–}4 days in normal physiology).

  • When transport fails

    • Primary driver: tubal damage and scarring → impaired cilia + muscular action.

    • Salpingitis (subacute/acute) following pelvic inflammatory disease (PID) = most frequent culprit.

  • Cellular Anatomy Snapshot

    • Tubal epithelium becomes edematous & loses ciliary density → ovum lodges and implants prematurely.

Risk Factors

  • Tubal pathology or scarring
    • Previous PID (often due to Neisseria gonorrhoeaeNeisseria\ gonorrhoeae or Chlamydia trachomatisChlamydia\ trachomatis)
    • Past ectopic pregnancy or tubal surgery (salpingostomy, sterilization, re‐anastomosis)

  • Reproductive/obstetric history
    • Infertility
    • Prior pregnancy loss (spontaneous or induced)

  • Contraception & devices
    • Current/remote intrauterine device (IUD) usage
    • Post‐sterilization failures

  • Structural
    • Uterine fibroids distorting tubo-uterine junction

  • Behavioral/other
    • Cigarette smoking (dose-dependent correlation)
    • Multiple sexual partners / unprotected intercourse (↑ STI risk)

Common Implantation Sites

  • Ordered list (descending frequency):
    \text{Ampullary} \; > \; \text{Isthmic} \; > \; \text{Interstitial (cornual)} \; > \; \text{Fimbrial} \; > \; \text{Tubo-ovarian ligament} \; > \; \text{Ovarian} \; > \; \text{Abdominal} \; > \; \text{Cervical}

Clinical Manifestations

  • Classic triad (appears in <50%50\%):
    • Abdominal pain (usually unilateral)
    • Amenorrhea / missed menses
    • Vaginal spotting or bleeding

  • Additional symptoms
    • Shoulder tip pain (referred via phrenic nerve due to hemoperitoneum)
    • Dizziness, syncope, urge to defecate (pelvic blood irritating rectal pouch)

  • Physical findings
    • Tender abdomen ± guarding
    • Pain on bimanual or speculum exam; cervical motion tenderness
    • Palpable adnexal mass (tubal ring) in some
    • Vital sign spectrum:

    • Hypotension & tachycardia (blood loss)

    • Occasional reflex bradycardia from peritoneal irritation
      • Usually afebrile (unless underlying infection)
      • Scant, dark bleeding from external os

Diagnostic Algorithm

  1. Initial encounter – any first-trimester pt with pain/bleeding is EP until ruled out.

  2. Transvaginal sonography (TVS) ± trans-abdominal (TAS) within ≤48 h\le 48\,h.

    • Empty uterus + adnexal mass or free fluid ⇒ presumptive EP.

  3. Quantitative serum β-hCG

    • Discriminatory zone for TVS ≈ 1500–3000 mIU/mL1500\text{–}3000\,mIU/mL

    • If β-hCG > discriminatory zone and no intrauterine gestational sac → high EP probability.

  4. Indeterminate scans

    • Serial β-hCG q 48 h48\,h:
      • Appropriate intrauterine rise ≈ ≥53%\ge 53\% increase → likely viable IUP.
      • Plateau / suboptimal rise → EP or failed IUP.

  5. Differential diagnoses ruled out

    • Ruptured corpus luteum, incomplete/missed abortion, appendicitis, salpingitis, ovarian torsion, nephrolithiasis.

Medical Management (Methotrexate Protocol)

  • Eligibility criteria
    • Hemodynamically stable & reliable follow-up
    • Unruptured mass <4 cm4\,cm
    • β-hCG <10 000 mIU/mL10\,000\,mIU/mL
    • No embryonic cardiac activity (relative)
    • Normal renal/hepatic function
    • No concurrent intrauterine pregnancy (confirmed by TVS)

  • Drug options mentioned
    • Methotrexate (antimetabolite) – first line
    • Adjunct/alternatives: prostaglandins, misoprostol, actinomycin‐D (rare)

  • Single-dose MTX regimen (common)
    • Day 0: MTX 50 mg/m250\,mg/m^2 IM
    • Check β-hCG on Day 4 & Day 7
    • Adequate response = ≥15%15\% decline from Day 4 → Day 7
    • If <15%15\% drop → repeat dose or surgical conversion.

  • Follow-through: serial β-hCG until undetectable to ensure complete resolution.

Surgical Management

  • Unruptured, fertility-desired
    • Laparoscopic linear salpingostomy → remove conceptus, preserve tube.

  • Ruptured with hemorrhage or unsuitable for MTX
    • Salpingectomy (partial/total) via laparoscopy or laparotomy (unstable pt).

  • Interdisciplinary note
    • Rh-negative women receive 300 μg300\,μg Rh immunoglobulin within 72 h72\,h.

Nursing Assessment & Care

  • Ongoing assessments
    • Monitor pain, vitals for shock, distention, vaginal bleeding.
    • Obtain labs: β-hCG, CBC, blood type & screen.

  • Pre-treatment preparation
    • Administer ordered analgesics.
    • Explain medication (MTX) or surgical steps.
    • Teach danger signs of rupture: sudden severe abd pain, shoulder pain, fainting.

  • Post-procedure
    • Emotional support; potential grief over pregnancy loss + fertility anxieties.
    • Discharge teaching: pelvic rest, no alcohol/folate supplements (MTX interacts), follow β-hCG schedule.

Prevention & Health Promotion

  • STI prevention → barrier methods, reduced partners, early treatment of PID.

  • Smoking cessation during childbearing years (smoking impairs tubal motility).

  • In IUD users: educate about PID warning signs (fever, pelvic pain, abnormal discharge).

  • Early prenatal care to confirm intrauterine location via early ultrasound.

Complications & Prognosis

  • Immediate: massive intraperitoneal hemorrhage, hypovolemic shock, death (if untreated).

  • Future fertility
    • After one EP, risk of recurrence ≈ 10–25%10\text{–}25\%.
    • Salpingectomy on one side still allows contralateral conception; salpingostomy retains tube but risk of repeat EP in same tube.

  • Psychological sequelae: anxiety, depression, PTSD over emergent surgery/pregnancy loss.

Ethical & Practical Considerations

  • Counseling around future reproduction: timing, need for early ultrasound in subsequent pregnancies.

  • Medical vs surgical choice: weighs fertility preservation, compliance capability, and resource availability.

  • Rh prophylaxis: preventing isoimmunization embodies beneficence toward future offspring.

  • In jurisdictions restricting pregnancy termination, EP management is universally recognized as life-saving and ethically permissible.

Key Take-Away “Mnemonic” – EP‐RISK

E – Early pregnancy pain/bleeding
P – PID history / Prior ectopic
R – Rupture risk → rapid shock
I – Imaging (TVS) + β-hCG serials
S – Single-dose MTX if stable
K – Knife (surgery) if unstable / contraindicated

Quick Reference Numbers

• 90%90\% tubal, 70%70\% ampullary
• Discriminatory β-hCG for TVS: 1500–3000 mIU/mL1500\text{–}3000\,mIU/mL
• MTX success criterion: ≥15%15\% β-hCG drop (Day 4→7)
• Recurrence risk: up to 25%25\%
• RhIG dose: 300 μg300\,μg within 72 h72\,h (if Rh-negative)

Integrative Links to Prior Content

  • Builds on understanding of normal fertilization journey & tubal peristalsis discussed in earlier reproductive physiology lectures.

  • Relates to inflammation pathways (PID) and microbiology of gonorrhea/chlamydia previously covered.

  • Pharmacology tie-in: MTX mechanism (inhibits dihydrofolate reductase) revisits folate metabolism block concepts.

End-of-Study Checklist

☑ Define EP and cite most common site.
☑ List ≥5 risk factors.
☑ Reproduce diagnostic β-hCG algorithm.
☑ State MTX eligibility & monitoring criteria.
☑ Outline surgical options & RhIG indication.
☑ Provide three prevention counseling points.